Literature DB >> 32071021

Introducing PHIL (precipitating hydrophobic injectable liquid) - a new embolic agent for the body interventional radiologist.

Akash Prashar1, Saqib Butt1, Nadeem Shaida1.   

Abstract

A number of embolic agents are currently available each with their own properties. Precipitating hydrophobic injectable liquid (PHIL) is a new dimethyl sulfoxide (DMSO) compatible embolic agent with a number of specific properties which make it of interest to interventional radiologists. We review the use of PHIL in a non-neurointerventional setting, describing its use in a range of procedures such as trauma embolization, pseudoaneurysm embolization, and tumor embolization. PHIL's properties include a lack of skin discoloration, the possibility of rapid injection and a lack of glare artifact on follow-up computed tomography imaging. These properties make it an important new tool in the armamentarium of the body interventional radiologist.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32071021      PMCID: PMC7051264          DOI: 10.5152/dir.2019.19063

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  8 in total

1.  A new liquid material for embolization of arteriovenous malformations.

Authors:  W Taki; Y Yonekawa; H Iwata; A Uno; K Yamashita; H Amemiya
Journal:  AJNR Am J Neuroradiol       Date:  1990 Jan-Feb       Impact factor: 3.825

2.  Intra-operative combustion of Onyx embolic material.

Authors:  S J Smith; A Thomas; R D Ashpole
Journal:  Br J Neurosurg       Date:  2009-02       Impact factor: 1.596

3.  Treatment of Type II Endoleaks with a Novel Agent: Precipitating Hydrophobic Injectable Liquid (PHIL).

Authors:  Amir Helmy; Nadeem Shaida
Journal:  Cardiovasc Intervent Radiol       Date:  2017-02-13       Impact factor: 2.740

4.  In vivo evaluation of the new PHIL low viscosity in a swine rete mirabile model.

Authors:  Edgar A Samaniego; Colin P Derdeyn; Minako Hayakawa; David Hasan; Santiago Ortega-Gutierrez
Journal:  Interv Neuroradiol       Date:  2018-07-04       Impact factor: 1.610

5.  Preliminary experience with the liquid embolic material agent PHIL (Precipitating Hydrophobic Injectable Liquid) in treating cranial and spinal dural arteriovenous fistulas: technical note.

Authors:  Joe J Leyon; Swarupsinh Chavda; Allan Thomas; Saleh Lamin
Journal:  J Neurointerv Surg       Date:  2015-05-20       Impact factor: 5.836

6.  Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model.

Authors:  D F Vollherbst; C M Sommer; C Ulfert; J Pfaff; M Bendszus; M A Möhlenbruch
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-18       Impact factor: 3.825

7.  Preliminary experience with squid: a new liquid embolizing agent for AVM, AV fistulas and tumors.

Authors:  Ilkay Akmangit; Ergun Daglioglu; Tunca Kaya; Fatih Alagoz; Mert Sahinoglu; Ahmet Peker; Shehram Derakshani; Dogan Dede; Deniz Belen; Anil Arat
Journal:  Turk Neurosurg       Date:  2014       Impact factor: 1.003

8.  Preliminary experience with Precipitating Hydrophobic Injectable Liquid (PHIL) in treating cerebral AVMs.

Authors:  Edgar A Samaniego; Vladimir Kalousek; German Abdo; Santiago Ortega-Gutierrez
Journal:  J Neurointerv Surg       Date:  2016-01-27       Impact factor: 5.836

  8 in total
  2 in total

Review 1.  Emerging Polymer Materials in Trackable Endovascular Embolization and Cell Delivery: From Hype to Hope.

Authors:  Md Mohosin Rana; Marites P Melancon
Journal:  Biomimetics (Basel)       Date:  2022-06-10

Review 2.  Surgical management of auricular arteriovenous malformations: A literature review.

Authors:  Ruiquan Liu; Jianguo Chen; Litao Jia; Bo Pan; Haiyue Jiang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.